⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11542628 | 0.79 | — | — | |
| SCHEMBL1147121 | 0.78 | — | — | |
| SCHEMBL3190326 | 0.77 | EPHX1 (0.61) | — | |
| SCHEMBL10117997 | 0.77 | — | — | |
| SCHEMBL248984 | 0.77 | TDP1 (0.48) | — | |
| SCHEMBL9885435 | 0.77 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL6969449 | 0.75 | — | — | |
| SCHEMBL12012103 | 0.75 | HSD17B10 (0.41) | — | |
| SCHEMBL14959695 | 0.75 | ACHE (0.48) | — | |
| Methyl Alcohol SCHEMBL2298111 | 0.75 | TDP1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114213284-B | (9H-fluoren-9-yl) -decyl (2-oxo-ethyl) carbamic acid methyl ester and synthesis method thereof | 丽珠集团福州福兴医药有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-114213284-A | (9H-fluorene-9-yl) -decyl (2-oxoethyl) methyl carbamate and synthetic method thereof | 丽珠集团福州福兴医药有限公司 | 2022-03-22 | — | — | CN | claimed |
| WO-2024238872-A2 | ISOINDOLINONE-GLUTARIMIDE ANTIBODY CONJUGATES, AND USES THEREOF | FIREFLY BIO, INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| CN-114213284-B | (9H-fluoren-9-yl) -decyl (2-oxo-ethyl) carbamic acid methyl ester and synthesis method thereof | 丽珠集团福州福兴医药有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-114213284-B | (9H-fluoren-9-yl) -decyl (2-oxo-ethyl) carbamic acid methyl ester and synthesis method thereof | 丽珠集团福州福兴医药有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-114213284-B | (9H-fluoren-9-yl) -decyl (2-oxo-ethyl) carbamic acid methyl ester and synthesis method thereof | 丽珠集团福州福兴医药有限公司 | 2023-08-01 | — | — | CN | disclosed |
| WO-2023129518-A1 | TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES | REGENERON PHARMACEUTICALS, INC. (US) | 2023-07-06 | — | — | WO | disclosed |
| CN-114213284-A | (9H-fluorene-9-yl) -decyl (2-oxoethyl) methyl carbamate and synthetic method thereof | 丽珠集团福州福兴医药有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114213284-A | (9H-fluorene-9-yl) -decyl (2-oxoethyl) methyl carbamate and synthetic method thereof | 丽珠集团福州福兴医药有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114213284-A | (9H-fluorene-9-yl) -decyl (2-oxoethyl) methyl carbamate and synthetic method thereof | 丽珠集团福州福兴医药有限公司 | 2022-03-22 | — | — | CN | disclosed |
| EP-3886904-A1 | IRAK DEGRADERS AND USES THEREOF | Kymera Therapeutics, Inc. (US) | 2021-10-06 | — | — | EP | disclosed |
| WO-2007120098-A1 | THIOXANTHINE DERIVATIVES AND THEIR USE AS INHIBITORS OF MPO | ASTRAZENECA AB (SE) | 2007-10-25 | — | — | WO | disclosed |
| US-7273909-B2 | Polyethylene glycol aldehydes | HOFFMANN-LA ROCHE INC. (US) | 2007-09-25 | — | — | US | disclosed |
| WO-2006113458-A1 | HETEROCYCLIC INHIBITORS OF PROTEIN ARGININE METHYL TRANSFERASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-10-26 | — | — | WO | disclosed |
| EP-0339811-B1 | AQUEOUS BASED PHARMACEUTICAL COATING COMPOSITION FOR DOSAGE FORMS | ALZA CORPORATION (US) | 1993-02-10 | — | — | EP | disclosed |
| US-5160743-A | Annealed composition for pharmaceutically acceptable drug | ALZA CORPORATION (US) | 1992-11-03 | — | — | US | disclosed |
| US-5024842-A | Annealed coats | ALZA CORPORATION (US) | 1991-06-18 | — | — | US | disclosed |
| US-5006346-A | Delivery system | ALZA CORPORATION (US) | 1991-04-09 | — | — | US | disclosed |
| US-4931285-A | Aqueous based pharmaceutical coating composition for dosage forms | ALZA CORPORATION (US) | 1990-06-05 | — | — | US | disclosed |
| EP-0339811-A2 | Aqueous based pharmaceutical coating composition for dosage forms | ALZA CORPORATION (US) | 1989-11-02 | — | — | EP | disclosed |